REVIEW PAPER
Eosinophilic esophagitis in children – current state of the problem
More details
Hide details
1
Institute of Paediatrics, Obstetrics and Gynaecology named after Academician O.M. Lukyanova, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
Submission date: 2019-10-14
Final revision date: 2019-11-07
Acceptance date: 2019-12-14
Publication date: 2019-12-31
Pediatr Pol 2019;94(6):373-378
KEYWORDS
TOPICS
ABSTRACT
In recent years, eosinophilic esophagitis (EE) has become a general clinical problem for allergists and gastroenterologists. The prevalence of EE is two times more likely to occur in children than in adults. Despite the large number of studies, it is considered that the aetiology and pathogenesis of EE have not been completely determined. The peculiarity of EE is that inflammatory changes are focal and evenly cover the distal and proximal oesophagus. During the allergic inflammatory process of the epithelium the oesophagus acquires hyperplastic characteristics, which causes the accumulation of eosinophils within it. The clinical picture of EE is nonspecific and varies according to the child’s age and the degree of progression of the disease. It is known that the onset of EE in children or adolescents subsequently leads to the need for endoscopic and surgical correction of dysphagia, strictures, narrowing of the oesophagus in a low number of these patients.
REFERENCES (86)
1.
Budkina TN, Sadikov IS, Makarova SG, et al. Eosinophilic esophagitis in children. Review paper. Questions of modern pediatrics 2016; 15: 239-249.
2.
Aceves SS. Food allergy testing in eosinophilic esophagitis: what the gastroenterologist needs to know. Clin Gastroenterol Hepatol 2014; 12: 1216-1223.
3.
Dellon ES, Gonsalves N, Hirano I, et al. ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE). The American Journal of Gastroenterology. Am J Gastroenterol 2013; 108: 679-692.
4.
Ivashkin VT, Baranskaya EK, Trukhmanov AS, et al. Eosinophilic esophagitis. Study Guide for Doctors. M.: AISPI RAS 2013; 80.
5.
Chen JW, Kao JY. Eosinophilic esophagitis: update on management and controversies. BMJ 2017; 359: j4482.
6.
Carr S, Chan ES, Watson W. Eosinophilic esophagitis. Allergy Asthma Clin Immunol 2018; 14 (Suppl 2): 58.
7.
Papadopoulou A, Koletzko S, Heuschkel R, et al. Management guidelines of eosinophilic esophagitis in childhood. J Pediatr Gastroenterol Nutr 2014; 58: 107-118.
8.
Attwood SE, Smyrk TC, Demeester TR, et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993; 38: 109-116.
9.
Straumann A, Spichtin HP, Bernoulli R, et al. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings [in German]. Schweiz Med Wochenschr 1994; 124: 1419-1429.
10.
Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995; 109: 1503-1512.
11.
Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009; 137: 1238-1249.
12.
Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342-1363.
13.
Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20.e6; quiz 1-2.
14.
Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013; 108: 679-692; quiz 693.
15.
Steinbach EC, Hernandez M, Dellon ES, et al. Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and Management. J Allergy Clin Immunol Pract September/October 2018; 6: 1483-1495.
16.
Lucendo AJ, Molina-Infante J, Arias A, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J 2017; 5: 335-358.
17.
Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3: 1198-1206.
18.
Iwanczak B, Janczyk W, Ryzko J, et al. Eosinophilic esophagitis in children: frequency, clinical manifestations, endoscopic findings, and seasonal distribution. Adv Med Sci 2011; 56: 151-157.
19.
Ally MR, Maydonovitch CL, Betteridge JD, et al. Prevalence of eosinophilic esophagitis in a United States military healthcare population. Dis Esophagus 2015; 28: 505-511.
20.
Dellon ES, Jensen ET, Martin CF, et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol 2014; 12: 589-596.
21.
Hruz P, Straumann A, Bussmann C, et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population based study in Olten County, Switzerland. J Allergy Clin Immunol 2011; 128: 1349-1350.
22.
Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009; 7: 1055-1061.
23.
Kapel RC, Miller JK, Torres C, et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008; 134: 1316-1321.
24.
Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007; 102: 2627-2632.
25.
Bohm M, Malik Z, Sebastiano C, et al. Mucosal eosinophilia: prevalence and racial/ethnic differences in symptoms and endoscopic findings in adults over 10 years in an urban hospital. J Clin Gastroenterol 2012; 46: 567-574.
26.
Sperry SLW, Woosley JT, Shaheen NJ, et al. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol 2012; 107: 215-221.
27.
Alexander ES, Martin LJ, Collins MH, et al. Twin and family stu- dies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol 2014; 134: 1084-1092.e1.
28.
D’Alessandro A, Esposito D, Pesce M, et al. Eosinophilic esophagitis: From pathophysiology to treatment. World J Gastrointest Pathophysiol 2015; 6: 150-158.
29.
Gonzalez-Cervera J, Arias A, Redondo-Gonzalez O, et al. Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol 2017; 118: 582-590.e2.
30.
Ram G, Lee J, Ott M, et al. Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Allergy Asthma Immunol 2015; 115: 224-228.
31.
Antico A, Fante R. Esophageal hypereosinophilia induced by grass sublingual immunotherapy. J Allergy Clin Immunol 2014; 133: 1482-1484.
32.
Miehlke S, Alpan O, Schroder S, et al. Induction of eosinophilic esophagitis by sublingual pollen immunotherapy. Case Rep Gastroenterol 2013; 7: 363-368.
33.
Remedios M, Campbell C, Jones DM, et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 2006; 63: 3-12.
34.
Odze RD. Pathology of eosinophilic esophagitis: what the clinician needs to know. Am J Gastroenterol 2009; 104: 485-490.
35.
Lutsik OD, Ivanova AY, Kabak KS, et al. Human histology. Kiev 2003: 593.
36.
Binkovitz LA, Lorenz EA, Di Lorenzo C, et al. Pediatric eosinophilic esophagitis: radiologic findings with pathologic correlation. Pediatr Radiol 2010; 40: 714-719.
37.
Chehade M, Sampson HA, Morotti RA, et al. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2007; 45: 319-328.
38.
Dellon ES, Kim HP, Sperry SL, et al. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc 2014; 79: 577-585.e4.
39.
Aceves SS, Newbury RO, Dohil MA, et al. A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. Ann Allergy Asthma Immunol 2009; 103: 401-406.
40.
Mukkada VA, Haas A, Maune NC, et al. Feeding dysfunction in children with eosinophilic gastrointestinal diseases. Pediatrics 2010; 126: e672-677.
41.
Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009; 48: 30-36.
42.
Mackenzie SH, Go M, Chadwick B, et al. Clinical trial: eosinophilic esophagitis in patients presenting with dysphagia: a prospective analysis. Aliment Pharmacol Ther 2008; 28: 1140-1146.
43.
Fass R, Gasiorowska A. Refractory GERD: what is it? Curr Gastroenterol Rep 2008; 10: 252-257.
44.
Croese J, Fairley SK, Masson JW, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc 2003; 58: 516-522.
45.
Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009; 7: 1305-1313; quiz 261.
46.
Kahn J, Bussmann C, Beglinger C, et al. Exercise-induced chest pain: an atypical manifestation of eosinophilic esophagitis. Am J Med 2015; 128: 196-199.
47.
Rassbach W, Rubenstein JH, Elkins M, et al. Age-based differences in the diagnosis and management of esophageal eosinophilia. J Allergy Clin Immunol Pract 2015; 3: 81-87.e1.
48.
Umanets TR, Kreposniak AA. Asthma combined with eosinophilic esophagitis in children: current condition of the problem. Review paper. Asthma and Allergy 2019; 1: 36-43.
49.
Lucendo AJ, Pascual-Turrion JM, Navarro M, et al. Endoscopic, bioptic and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy 2007; 39: 765-771.
50.
Muller S, Puhl S, Vieth M, et al. Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy 2007; 39: 339-344.
51.
Abhishek Watts, Jeffrey A. Alexander, Sandeep K; Gupta Gastrointestinal endoscopy 2016; 83: 307-308. www.giejournal.org.
52.
Gupta SK, Fitzgerald JF, Chong SK, et al. Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children? Gastrointest Endosc 1997; 45: 485-489.
53.
Kim HP, Vance RB, Shaheen NJ, et al. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 988-996.e5.
54.
Straumann A, Rossi L, Simon HU, et al. Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Gastrointest Endosc 2003; 57: 407-412.
55.
Straumann A, Spichtin HP, Bucher KA, et al. Eosinophilic esophagitis: red on microscopy, white on endoscopy. Digestion 2004; 70: 109-116.
56.
Alexander JA, Jung KW, Arora AS, et al. Swallowed fluticasone improves histologic but not symptomatic responses of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2012; 10: 742-749.e1.
57.
Dohil R, Newbury R, Fox L, et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010; 139: 418-429.
58.
Gonsalves N, Yang GY, Doerfler B, et al. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 2012; 142: 1451-1459.e1; quiz e14-e15.
59.
Helou EF, Simonson J, Arora AS. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol 2008; 103: 2194-2199.
60.
Kagalwalla AF, Akhtar N, Woodruff SA, et al. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol 2012; 129: 1387-1396.e7.
61.
Lieberman JA, Morotti RA, Konstantinou GN, et al. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort. Allergy 2012; 67: 1299-1307.
62.
Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol 2008; 6: 165-173.
63.
Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010; 139: 1526-1537.
64.
Abu-Sultaneh SM, Durst P, Maynard V, et al. Fluticasone and food allergen elimination reverse subepithelial fibrosis in children with eosinophilic esophagitis. Dig Dis Sci 2011; 56: 97-102.
65.
Aceves SS, Newbury RO, Chen D, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65: 109-116.
66.
Carlson DA, Hirano I, Zalewski A, et al. Improvement in esophageal distensibility in response to medical and diet therapy in eosinophilic esophagitis. Clin Transl Gastroenterol 2017; 8: e119.
67.
Lucendo AJ, Arias A, de Rezende LC, et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. J Allergy Clin Immunol 2011; 128: 1037-1046.
68.
Rajan J, Newbury RO, Anilkumar A, et al. Longterm assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol 2016; 137: 147-156.e8.
69.
Wolf WA, Jerath MR, Sperry SL, et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014; 12: 1272-1279.
70.
Gonsalves N. Eosinophilic esophagitis: history, nomenclature, and diagnostic guidelines. Gastrointest Endosc Clin N Am 2008; 18: 1-9; vii.
71.
Liacouras CA. Eosinophilic esophagitis in children and adults.
72.
J Pediatr Gastroenterol Nutr 2003; 37 (Suppl 1): S23-28.
73.
Rothenberg ME, Mishra A, Collins MH, et al. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001; 108: 891-894.
74.
van Rhijn BD, Verheij J, van den Bergh Weerman MA, et al. Histological response to fluticasone propionate in patients with eosinophilic esophagitis is associated with improved functional esophageal mucosal integrity. Am J Gastroenterol 2015; 110: 1289-1297.
75.
Warners MJ, Vlieg-Boerstra BJ, Verheij J, et al. Esophageal and small intestinal mucosal integrity in eosinophilic esophagitis and response to an elemental diet. Am J Gastroenterol 2017; 112: 1061-1071.
76.
Dellon ES, Gibbs WB, Rubinas TC, et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc 2010; 71: 706-712.
77.
Hirano I. Dilation in eosinophilic esophagitis: to do or not to do? Gastrointest Endosc 2010; 71: 713-714.
78.
Jung KW, Gundersen N, Kopacova J, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc 2011; 73: 15-21.
79.
Straumann A. The natural history and complications of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008; 18: 99-118; ix.
80.
Straumann A, Conus S, Degen L, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011; 9: 400-409.
81.
Reed CC, Wolf WA, Cotton CC, et al. Optimal histologic cutpoints for treatment response in patients with eosinophilic esophagitis: analysis of data from a prospective cohort study. Clin Gastroenterol Hepatol 2018; 16: 226-233.e2.
82.
Wolf WA, Cotton CC, Green DJ, et al. Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis. J Gastroenterol Hepatol Res 2015; 4: 1780-1787.
83.
Evan S. Dellon et al.; Clinical-Alimentary tract. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the Agree Conference. Gastroenterology 2018; 155: 1022-1033.
84.
Dellon ES, Sheikh A, Speck O, et al. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology 2012; 143: 321-324.
85.
Gupta SK, Vitanza JM, Collins MH. Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015; 13: 66-76.
86.
Kuchen T, Straumann A, Safroneeva E, et al. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis. Allergy 2014; 69: 1248-1254.